Can C-reactive protein predict coagulation in off pump coronary artery bypass grafting? A cohort study

Xiaojie Liu1,2, Yang Yu2, Lijuan Wang2

  • 1Department of Anestheiology, the Affiliated Hospital of Qingdao University, No. 59, Haier Road, Qingdao, Shandong province, China.

Insights

Preoperative C-reactive protein (CRP) levels predict reduced postoperative bleeding in off-pump coronary artery bypass grafting (CABG) patients. This finding suggests CRP may serve as a novel marker for bleeding risk in cardiovascular surgery.

Area of Science:

  • Cardiovascular Surgery
  • Biomarkers
  • Inflammation

Background:

  • Previous research indicated C-reactive protein (CRP) predicts bleeding post-on-pump CABG.
  • The role of CRP in predicting bleeding after off-pump CABG remains unevaluated.

Purpose of the Study:

  • To determine if preoperative C-reactive protein (CRP) is a novel marker for postoperative bleeding in patients undergoing off-pump coronary artery bypass grafting (CABG).

Main Methods:

  • Retrospective cohort study involving 537 patients undergoing off-pump isolated primary CABG.
  • Analysis of preoperative data, including CRP levels, correlated with postoperative bleeding volume within 24 hours.
  • Multivariable regression analyses were performed to identify independent predictors.

Main Results:

  • Higher preoperative C-reactive protein (CRP) concentration was significantly associated with lower postoperative bleeding volume (B = -0.089, P < 0.05).
  • Fibrinogen levels also showed a correlation with bleeding volume (B = 0.594, p < 0.001).

Conclusions:

  • Preoperative CRP concentration is an independent predictor of postoperative bleeding volume within 24 hours after off-pump CABG.
  • CRP shows potential as a novel coagulation index for patients with coronary artery atherosclerotic disease.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
195
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
290
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21